Contributed to HyLAW (legal frameworks for hydrogen/fuel cells) and EUROfusion, both linked to their core cryogenics and energy mandate.
NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA
Romanian national institute specializing in cryogenics, hydrogen technologies, and isotope science, expanding into battery materials and digital health platforms.
Their core work
ICSI Rm. Vâlcea is Romania's national institute specializing in cryogenics, isotope separation, and hydrogen technologies — fields rooted in the country's heavy water production heritage. Their H2020 participation reveals capabilities spanning hydrogen and fuel cell regulation, advanced battery electrode development, and pharmaceutical supply chain digitization. They bring materials science and electrochemistry expertise to European consortia, particularly where hydrogen storage, energy conversion, or isotopic processes are involved.
What they specialise in
The Hydra project (EUR 493K, their largest grant) focuses on hybrid power-energy electrodes for next-generation lithium-ion batteries.
PharmaLedger involved blockchain-based frameworks for counterfeit medicines detection and machine-learning health data marketplaces.
Participated in the flagship EUROfusion programme as a third party, likely contributing cryogenics or isotope handling expertise.
How they've shifted over time
Their early H2020 involvement (2014-2017) centered on large-scale energy infrastructure — nuclear fusion via EUROfusion and hydrogen regulatory landscape through HyLAW — reflecting their traditional cryogenics and isotopic mandate. From 2020 onward, they branched into two distinct directions: electrochemistry for battery materials (Hydra) and digital health platforms using blockchain (PharmaLedger). This suggests a deliberate diversification from their legacy energy focus toward materials science and data-driven applications.
Moving from traditional cryogenics/hydrogen into electrochemical energy storage, positioning themselves as a battery materials research partner for the European Green Deal era.
How they like to work
ICSI has never coordinated an H2020 project, consistently joining as a participant or third party in large international consortia. With 259 unique partners across 31 countries, they operate as a specialized contributor embedded in broad European networks rather than leading their own initiatives. This makes them a low-risk, experienced consortium partner who understands their role within large collaborative structures.
Extensively networked across 31 countries with 259 unique consortium partners, largely through participation in mega-projects like EUROfusion. Their reach is pan-European, though the high partner count reflects large consortium membership rather than deep bilateral ties.
What sets them apart
ICSI occupies a rare niche as one of Romania's few institutes combining cryogenics, isotope science, and hydrogen technology expertise — capabilities that are scarce in Central and Eastern Europe. Their crossover into battery electrochemistry (Hydra) makes them an interesting partner for energy storage projects needing materials science from a cost-competitive EU-13 country. For consortium builders, they offer genuine lab infrastructure and domain expertise at Romanian cost rates, which can be attractive for budget balancing.
Highlights from their portfolio
- HydraTheir largest single grant (EUR 493K) and most technically focused project — hybrid electrodes for lithium-ion batteries, signaling a strategic bet on energy storage.
- PharmaLedgerAn unexpected pivot for a cryogenics institute into blockchain and health data, demonstrating adaptability and digital capabilities beyond their traditional mandate.
- EUROfusionEurope's flagship fusion energy programme — participation (even as third party) signals recognized competence in cryogenics or isotope handling at the highest level.